About the Company
NeurAxis, Inc
BUSINESS DESCRIPTION
NeurAxis is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. NeurAxis is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. We believe that superior science, evidence-based research, and building on its unparalleled body of clinical evidence is necessary for adoption by the medical...
NeurAxis, Inc News
-
NeurAxis Submits Application to FDA to Expand IB-Stim Label...
06/07/2024 03:41 PMNeurAxis Submits Application to FDA to Expand IB-Stim Label...
-
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim La...
06/07/2024 01:00 PMCARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commer...
-
NeurAxis Reports First Quarter 2024 Financial Results...
05/22/2024 12:00 PMCARMEL, Ind., May 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference o...
05/21/2024 01:00 PMCARMEL, Ind., May 21, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in F...
05/16/2024 01:00 PMCARMEL, Ind., May 16, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesda...
05/15/2024 08:30 PMCARMEL, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis Announces New Medical Policy Coverage in North Dakota...
04/23/2024 01:00 PMCARMEL, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company comme...
-
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript...
04/12/2024 12:44 PMNeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript April 9, 2024 NeurAxis, Inc. isn’t one of the 30 most popular stocks among hedge funds at the en...
-
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results...
04/09/2024 08:05 PMCARMEL, Ind., April 09, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company comme...
Disclaimer: